- Home
- UTHR vs UMC Comparison
UTHR vs UMC Comparison
Compare UTHR & UMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTHR
- UMC
- Stock Information
- Founded
- UTHR 1996
- UMC 1980
- Country
- UTHR United States
- UMC Taiwan
- Employees
- UTHR N/A
- UMC N/A
- Industry
- UTHR Biotechnology: Pharmaceutical Preparations
- UMC Semiconductors
- Sector
- UTHR Health Care
- UMC Technology
- Exchange
- UTHR Nasdaq
- UMC Nasdaq
- Market Cap
- UTHR 16.1B
- UMC 16.9B
- IPO Year
- UTHR 1999
- UMC 2000
- Fundamental
- Price
- UTHR $367.97
- UMC $6.06
- Analyst Decision
- UTHR Buy
- UMC Sell
- Analyst Count
- UTHR 14
- UMC 4
- Target Price
- UTHR $378.36
- UMC $7.40
- AVG Volume (30 Days)
- UTHR 280.3K
- UMC 10.6M
- Earning Date
- UTHR 02-19-2025
- UMC 01-21-2025
- Dividend Yield
- UTHR N/A
- UMC 7.63%
- EPS Growth
- UTHR 25.10
- UMC N/A
- EPS
- UTHR 22.72
- UMC 0.13
- Revenue
- UTHR $2,756,200,000.00
- UMC $7,143,186,732.00
- Revenue This Year
- UTHR $26.19
- UMC $6.20
- Revenue Next Year
- UTHR $10.79
- UMC $8.02
- P/E Ratio
- UTHR $16.19
- UMC $10.36
- Revenue Growth
- UTHR 25.04
- UMC N/A
- 52 Week Low
- UTHR $208.62
- UMC $5.88
- 52 Week High
- UTHR $417.82
- UMC $9.00
- Technical
- Relative Strength Index (RSI)
- UTHR 53.51
- UMC 34.57
- Support Level
- UTHR $357.25
- UMC $6.09
- Resistance Level
- UTHR $372.34
- UMC $6.42
- Average True Range (ATR)
- UTHR 8.70
- UMC 0.15
- MACD
- UTHR 0.91
- UMC -0.02
- Stochastic Oscillator
- UTHR 79.59
- UMC 19.89
About UTHR United Therapeutics Corporation
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.
About UMC United Microelectronics Corporation (NEW)
Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 7% market share in 2023 after TSMC and SMIC. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the us, and South Korea. UMC features a diverse customer base that includes Texas Instruments, MediaTek, Qualcomm, Broadcom, Xilinx, and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 20,000 people.